Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)
Australia · Delayed Price · Currency is AUD | Market Cap | 15.76B -14.7% |
| Revenue (ttm) | 1.89B +14.2% |
| Net Income | 383.13M +144.8% |
| EPS | 0.65 +144.1% |
| Shares Out | n/a |
| PE Ratio | 41.14 |
| Forward PE | 38.17 |
| Dividend | 0.46 (1.72%) |
| Ex-Dividend Date | Dec 3, 2025 |
| Volume | 358,867 |
| Average Volume | 397,759 |
| Open | 27.13 |
| Previous Close | 26.99 |
| Day's Range | 26.54 - 27.14 |
| 52-Week Range | 26.51 - 35.31 |
| Beta | 0.85 |
| RSI | 21.92 |
| Earnings Date | May 25, 2026 |
About ASX:FPH
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respir... [Read more]
Financial Performance
In fiscal year 2025, ASX:FPH's revenue was 2.02 billion, an increase of 15.96% compared to the previous year's 1.74 billion. Earnings were 377.20 million, an increase of 184.46%.
Financial numbers in NZD Financial StatementsNews
Fisher & Paykel Healthcare: Why the market darling is suddenly out of favour – Stock Takes
The company still trades on a price/earnings multiple of 43 times.
Fisher and Paykel Healthcare Stock Trades at 48x Earnings — And Long-Term Holders Aren’t Selling
Certain stocks don’t make headlines unless something goes wrong, don’t trend on Reddit, and don’t appear on CNBC’s lower thirds. Among them is Fisher & Paykel Healthcare. It has the reputation of a br...